Polylacticcoglycolic acid – PLGA

Abstract Poly(lactic-co-glycolic acid) (PLGA)-based microparticles and implants are of continuously increasing importance as parenteral controlled drug delivery systems. However, the...

Abstract Severe injuries can compromise the healing process, leading to infections and complications. Bioengineered artificial skin substitutes (BASS) are used...

Abstract RNA interference via small interfering RNA (siRNA) offers promising potential for treating glioblastoma (GB), the most common and aggressive...

Abstract Alzheimer’s disease (AD) is a long-term neurological disorder associated with neuroinflammation and amyloid-beta (Aβ) aggregation, which leads to a...

Abstract Psoriasis is a hereditary, autoimmune, chronic illness that influences the immune system and can have both cutaneous and systemic...

Abstract Postbiotics are substances released or produced by the metabolic activity of microorganisms that have a beneficial effect on the...

Abstract The recent advancement of 3D-printed drugs is an emerging technology that has the potential for effective and safe oral...

Abstract Vaginal drug delivery has gained significant interest due to its numerous advantages, such as good blood flow, bypassing the...

Abstract The incorporation of poorly soluble active ingredients, which make up the majority of the molecules in development, into fixed-dose...

Abstract Drug delivery products based on poly(lactic-co-glycolic acid) (PLGA) often have multiphasic drug release profiles with slow “lag phase(s)” and...